About Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and weight management (Zepbound). It has shown superior weight loss outcomes compared to semaglutide in head-to-head trials. The dual-agonist mechanism provides enhanced metabolic benefits.
Tirzepatide & Weight Loss
Tirzepatide is FDA-approved as Zepbound for chronic weight management. See the TruthTides evidence library for graded trial summaries and citations.
Content sourced from existing TruthTides clinical reference documentation. This is informational only. Consult a qualified physician.
Find a Tirzepatide prescriber in San Diego
Browse qualified physicians who prescribe Tirzepatide in the San Diego area, or search nationwide via telehealth.
Ask TruthSource AI
Ask anything about Tirzepatide for Weight Loss
Get a guardrailed, evidence-anchored answer from our clinical reference tool.
Open Reference ToolFind a Doctor
Search verified Tirzepatide prescribers nationwide
Filter by peptide, location, and telehealth availability.
Open Physician FinderAlso in San Diego
Tirzepatide for Weight Loss in Other Cities
This content is sourced from existing TruthTides clinical reference documentation. It does not constitute medical advice or treatment recommendations. Consult a qualified physician before starting any peptide therapy.